L Delrue
Overview
Explore the profile of L Delrue including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
69
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sutera P, Shetty A, Hakansson A, Van der Eecken K, Song Y, Liu Y, et al.
Ann Oncol
. 2023 May;
34(7):605-614.
PMID: 37164128
Background: Metastatic castration-sensitive prostate cancer (mCSPC) is commonly classified into high- and low-volume subgroups which have demonstrated differential biology, prognosis, and response to therapy. Timing of metastasis has similarly demonstrated...
2.
Van den Broecke M, Leenknegt B, Delrue L
J Belg Soc Radiol
. 2019 Mar;
103(1):15.
PMID: 30828697
No abstract available.
3.
De Kock I, Dekeyzer S, Smet B, Delrue L
JBR-BTR
. 2014 Mar;
96(6):394.
PMID: 24617192
No abstract available.
4.
Berkovic P, Van De Voorde L, De Meerleer G, Delrue L, Speleers B, Van Belle S, et al.
Strahlenther Onkol
. 2013 Dec;
190(2):223-8.
PMID: 24306063
Background: Pseudomyxoma peritonei (PMP) is a rare clinical syndrome characterized by mucinous peritoneal disease arising from disseminated peritoneal adenomucinosis. Primary treatment involves a combination of cytoreductive surgery with hyperthermic intraperitoneal...
5.
Dekeyzer S, Gosselin R, Delrue L
JBR-BTR
. 2013 Apr;
96(1):45.
PMID: 23610888
No abstract available.
6.
Vandecasteele K, Makar A, Van den Broecke R, Delrue L, Denys H, Lambein K, et al.
Strahlenther Onkol
. 2012 Apr;
188(7):576-81.
PMID: 22526231
Purpose: The goal of this work was to evaluate the feasibility and outcome of intensity-modulated arc therapy ± cisplatin (IMAT ± C) followed by hysterectomy for locally advanced cervical cancer....
7.
Hindryckx P, Staelens S, Devisscher L, Deleye S, De Vos F, Delrue L, et al.
Inflamm Bowel Dis
. 2011 Sep;
17(10):2058-64.
PMID: 21910167
Background: This study investigates whether deoxy-2-[18F]fluoro-d-glucose (FDG) micro-positron emission tomography (μPET)/computed tomography (CT) can serve as a tool for monitoring of the commonly used dextran sodium sulfate (DSS)-induced murine model...
8.
Delrue L, Blanckaert P, Mertens D, Van Meerbeeck S, Ceelen W, Duyck P
Abdom Imaging
. 2011 Aug;
37(4):595-601.
PMID: 21811851
Purpose: Perfusion CT can provide information regarding blood perfusion and permeability in (tumor) tissues in a non-invasive manner. In this study, values of CT perfusion parameters in several pancreas pathologies...
9.
Herregods N, Van Damme S, Delrue L, Verstraete K
JBR-BTR
. 2008 Apr;
90(6):541.
PMID: 18376775
No abstract available.
10.
Gosselin R, Smeets P, Delrue L, Duyck P
JBR-BTR
. 2007 Jun;
90(2):120-1.
PMID: 17555072
No abstract available.